In January 2022, Brazilian healthtech company Nilo Saúde announced a $10 million Series A funding round. Investors in the round included GFC, SoftBank Latin America Fund, Tau Ventures, MAYA Capital, and Canary Ventures. Nilo Saúde’s platform offers simple, integrated software for improved patient communication, enhanced telemedicine services, and smart clinical analytics. The start-up plans to use the new funding to improve the platform’s software, specifically to incorporate data analytics and automation.

Wilson Sonsini Goodrich & Rosati advised Nilo Saúde on the transaction. The Wilson Sonsini team includes Matt Squires, Cesar Fischer, and Kiri Yoshimura.

For more information, please see news coverage from LatamList.